MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2017 International Congress

    Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease

    G. Buongarzone, C. Fenoglio, J. Nicoli, E. Monfrini, I. Trezzi, A. Arighi, R. Del Bo, N. Bresolin, E. Scarpini, G. Comi, S. Corti, A. Di Fonzo (Milan, Italy)

    Objective: To determinate the frequencies of lysosomal glucocerebrosidase (GBA) common mutations in a large sample of neurodegenerative diseases including Alzheimer Disease (AD), Lewy Body Dementia (LBD), Amyotrophic…
  • 2017 International Congress

    Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.

    S. Ray, D. Park, D. Burdick, A. Griffith, J. Shaw, P. Agarwal (Kirkland, WA, USA)

    Objective:  We report two patients with Parkinson’s disease(PD) and Capgras syndrome (CS) with confusion of identify not just of close acquaintances but also of “self”.…
  • 2017 International Congress

    A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations

    S. Ramaswamy, W. Wen, G. Ramaswamy, L. Friedhoff (New York, NY, USA)

    Objective: To evaluate the safety and efficacy of nelotanserin in Lewy body dementia subjects experiencing visual hallucinations. Background: Nelotanserin is a selective 5HT2A receptor inverse…
  • 2017 International Congress

    Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments

    M. Miyata, S. Kakeda, J. Moriya, H. Narimatsu, T. Sato, H. Adachi, Y. Wang, Y. Korogi (Kitakyushu, Japan)

    Objective: We compared quantitative susceptibility mapping (QSM) values in the hippocampi among patients with Parkinson disease (PD) and PD with dementia (PDD)/ Lewy body dementia…
  • 2017 International Congress

    Causes, Complications and Outcomes of Hospitalization in Patients with Dementia with Lewy Bodies

    C. Spears, A. Besharat, D. Martinez-Ramirez, L. Almeida, M. Armstrong (Gainesville, FL, USA)

    Objective: To identify causes, complications and outcomes of hospitalization in patients with dementia with Lewy bodies (DLB). Background: Hospitalization is a known contributor to morbidity…
  • 2017 International Congress

    Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in patients with Parkinson disease (PD) with dementia (PDD) and dementia with lewy bodies (DLB) by…
  • 2017 International Congress

    A case of Dementia with Lewy Bodies Co-Occuring with Multiple Sclerosis

    A. Hannoun, E. DeGrush, K. Smith, T. Kao, A. Deb (Worcester, MA, USA)

    Objective: To describe a unique case of Dementia with Lewy bodies (DLB) co-occurrence with Multiple Sclerosis (MS) Background: Various movement disorders have been described in…
  • 2017 International Congress

    Effects of zonisamide, an anti-parkinsonian drug, on cognition and BPSD in DLB patients: A post-hoc analysis of DLB Ph2 study

    M. Murata, T. Odawara, O. Konishi, M. Nakamura, K. Kosaka (Tokyo, Japan)

    Objective: Based on the results of a phase 2 study to evaluate the efficacy of zonisamide in improving parkinsonism accompanying dementia with Lewy Bodies (DLB),…
  • 2017 International Congress

    [11C]PK11195 PET Imaging Reveals Neuroinflammation in Dementia with Lewy Bodies: NIMROD Study

    A. Surendranathan, L. Su, L. Passamonti, Y. Hong, W. Bevan-Jones, R. Arnold, P. Vázquez Rodríguez, E. Mak, T. Fryer, F. Aigbirhio, J. Rowe, J. O'Brien (Cambridge, United Kingdom)

    Objective: To determine if subjects with dementia with Lewy bodies(DLB) have increased microglial activation in vivo compared to matched healthy controls as assessed using PET…
  • 2017 International Congress

    Impaired Color Vision in Patients with DLB or Prodromal DLB.

    B. Tousi, P. Flanigan, M. Khosravi (Cleveland, OH, USA)

    Objective: We sought to characterize the prevalence of color vision impairment in DLB patients and investigate how color vision impairment in DLB patients was associated with other…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley